Caprock Group, Inc. Invitae Corp Transaction History

Caprock Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$14.7 - $28.67 $155,790 - $303,844	-10,598 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $117,405 - $181,800	-4,500 Reduced 29.81%	10,598 $357,000
Q1 2021 Apr 29, 2021	SELL	$33.06 - $56.93 $379,528 - $653,556	-11,480 Reduced 43.19%	15,098 $577,000
Q4 2020 Jan 29, 2021	BUY	$39.09 - $57.4 $627,159 - $920,925	16,044 Added 152.31%	26,578 $1.11 Million
Q3 2020 Oct 29, 2020	SELL	$28.43 - $44.67 $566,695 - $890,407	-19,933 Reduced 65.42%	10,534 $457,000
Q2 2020 Aug 05, 2020	SELL	$11.71 - $30.29 $129,020 - $333,735	-11,018 Reduced 26.56%	30,467 $923,000
Q1 2020 Apr 28, 2020	BUY	$7.64 - $27.5 $316,945 - $1.14 Million	41,485 New	41,485 $567,000
Q4 2017 Jan 17, 2018	SELL	$7.86 - $9.99 $116,917 - $148,601	-14,875 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$8.89 - $10.4 $132,238 - $154,700	14,875	14,875 $139,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.